BMO Capital Keeps Their Hold Rating on Genpact (G)
Genpact Is Maintained at Buy by Needham
Genpact Analyst Ratings
Genpact's Strategic Growth and Technological Advancements Drive Buy Rating Despite Lowered Guidance
Mizuho Securities Maintains Genpact(G.US) With Hold Rating, Maintains Target Price $55
TD Cowen Maintains Genpact(G.US) With Buy Rating, Cuts Target Price to $53
Genpact's Strategic Positioning Amid Timing Challenges: A Buy Opportunity
Research Alert: G: Lower 2025 Outlook Overshadows Q1 Top- And Bottom-line Beats
TD Cowen Maintains Genpact(G.US) With Buy Rating, Cuts Target Price to $58
Jefferies Maintains Genpact(G.US) With Buy Rating, Cuts Target Price to $56
Jefferies Remains a Buy on Genpact (G)
Genpact Is Maintained at Neutral by Mizuho
Jefferies Maintains Genpact(G.US) With Buy Rating, Raises Target Price to $65
Genpact's Promising Future: AI Innovation and Strategic Growth Lead to Buy Rating
Mizuho Securities Maintains Genpact(G.US) With Hold Rating, Announces Target Price $55
A Quick Look at Today's Ratings for Genpact(G.US), With a Forecast Between $55 to $58
Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating
Needham Maintains Buy on Genpact, Raises Price Target to $65
Genpact Analyst Ratings
BMO Capital Maintains Genpact(G.US) With Hold Rating, Raises Target Price to $58